Evidence map›Paper›PMID 30191175›Full record

ArticleScience advances2018

PGE

Catherine A Loynes, Jou A Lee, Anne L Robertson, Michael Jg Steel, Felix Ellett, Yi Feng, Bruce D Levy, Moira K B Whyte, Stephen A Renshaw

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 213 citations in OpenAlex.

  1. AA in Rheumatoid Arthritis and Lupus.Reviews of physiology, biochemistry and pharmacology · 2027
    Review
  2. Introduction.Reviews of physiology, biochemistry and pharmacology · 2027
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Frontiers in immunology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Beyond Killing: The Overlooked Contribution of Neutrophils to Tissue Repair.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Regulatory Effect of PGEBiomolecules · 2025
    Article
  18. Article
  19. Article
  20. Review

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Catherine A LoynesThe Bateson Centre, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.ORCID 0000-0002-7163-4938
Jou A LeeThe Bateson Centre, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
Anne L RobertsonThe Bateson Centre, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
Michael Jg SteelThe Bateson Centre, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.ORCID 0000-0002-6789-0381
Felix EllettThe Bateson Centre, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.ORCID 0000-0003-4941-4346
Yi FengMedical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-8021-7776
Bruce D LevyPulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-9515-5731
Moira K B WhyteMedical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-7788-1852
Stephen A RenshawThe Bateson Centre, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.ORCID 0000-0003-1790-1641
University of Sheffield · GBCentre for Inflammation Research · GBBoston Children's Hospital · USBrigham and Women's Hospital · USHarvard University · US

Funding

Resolution Mechanisms in Acute Inflammation: Resolution PharmacologyP01GM095467 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2011 to 2020
$14.8M
Specialized Pro-Resolving Mediators in AsthmaR01HL122531 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEVY, BRUCE D · 2014 to 2024
$4.7M
Monitoring peripheral blood leukocyte and immune responses in health and diseaseU24AI118656 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LEVY, BRUCE D, VOLDMAN, JOEL · 2015 to 2019
$1.9M
Medical Research Council G0700091Medical Research Council G0701932Medical Research Council MR/M004864/1Medical Research Council MR/P020941/1NHLBI NIH HHS R01 HL122531NIAID NIH HHS U24 AI118656NIGMS NIH HHS P01 GM095467Wellcome Trust
6 · The paper itself

Abstract

Neutrophils are the first immune cells recruited to a site of injury or infection, where they perform many functions. Having completed their role, neutrophils must be removed from the inflammatory site-either by apoptosis and efferocytosis or by reverse migration away from the wound-for restoration of normal tissue homeostasis. Disruption of these tightly controlled physiological processes of neutrophil removal can lead to a range of inflammatory diseases. We used an in vivo zebrafish model to understand the role of lipid mediator production in neutrophil removal. Following tailfin amputation in the absence of macrophages, neutrophillic inflammation does not resolve, due to loss of macrophage-dependent handling of eicosanoid prostaglandin E2 (PGE

Indexed as

AnimalsAnimals, Genetically ModifiedCell MovementDinoprostoneDisease Models, AnimalInflammationLipoxinsLipoxygenasesMacrophagesNeutrophilsPhenotypeReceptors, Prostaglandin E, EP4 SubtypeWounds and InjuriesZebrafishDinoprostonelipoxin A4LipoxinsLipoxygenasesReceptors, Prostaglandin E, EP4 Subtype

Identifiers

PMID30191175
PMCPMC6124908
OpenAlexW2765422662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.